Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lotus Lake Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 50
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 43
Rounds per year 2.17
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 4
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Manufacturing
Summary

In 2001 was created Lotus Lake Ventures, which is appeared as VC. The company was established in Asia in China. The main department of described VC is located in the Beijing.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Hisign Technology, Sensylink, Kanova

The important activity for fund was in 2018. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Lotus Lake Ventures, startups are often financed by Infotech Ventures, CrestValue, Anlongmed Fund. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Yingke Capital, Shenzhen Capital Group. In the next rounds fund is usually obtained by LYFE Capital, JD Capital, HY Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lotus Lake Ventures:
Typical Co-investors
Lotus Lake Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lotus Lake Ventures:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China Wisdom -
Cyber Carrier -
FCM Travel Solutions Boston, Massachusetts, United States
Governing Dynamics Venture Capital New York, New York, United States
Jiangyi Chuangtou China, Japan, Kagoshima Prefecture
Jingbei Investment Beijing, Beijing, China
Keolis France, Ile-de-France, Paris
Mayan Capital Fund Mérida, Mexico, Yucatán
Medina Capital Coral Gables, Florida, United States
National Spectrum Consortium -
O Victory Fund -
Science Ventures Denmark, Odense, Syddanmark
Shepherd Kaplan Krochuk Boston, Massachusetts, United States
THU Capital Beijing, Beijing, China
Watsco Ventures Florida, Miami, United States
X Capital China, Shanghai
YEI Innovation Fund Connecticut, New Haven, United States
YunDing Tech Taiwan, Taiwan Province, Toufen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Better Medtech

Health Care
Hospital
Medical
$15M12 Jan 2024 Jiading, Shanghai, China

Juzheng Medical

Manufacturing
Medical
Medical Device
30 Oct 2023 Hangzhou, Zhejiang, China

Kanova

Biopharma
Pharmaceutical
$15M25 Jul 2023 Gusu District, Jiangsu, China

Yanming Biology

Biotechnology
Pharmaceutical
Therapeutics
$108M10 Jul 2023 Changping, Beijing, China

VDJ

Biotechnology
Medical
Pharmaceutical
06 Jun 2023 Haidian District, Beijing, China

Sijian Bio

Biotechnology
Health Care
Pharmaceutical
$15M31 May 2023 Pudong, Shandong, China

Hongyun Biotech

Biotechnology
Therapeutics
$15M15 May 2023 Nanjing, Jiangsu, China

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
20 Mar 2023 Changping District, Beijing, China

Care

Hardware
Health Diagnostics
Medical
Software
27 Feb 2023 Beijing, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lotus Lake Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 50
Average round size 15M
Rounds per year 2.17
Peak activity year 2023
Lead investments 6
Follow on index 0.14
Exits 4
Group Appearance index 0.86

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Better Medtech

Health Care
Hospital
Medical
$15M12 Jan 2024 Jiading, Shanghai, China

Juzheng Medical

Manufacturing
Medical
Medical Device
30 Oct 2023 Hangzhou, Zhejiang, China

Kanova

Biopharma
Pharmaceutical
$15M25 Jul 2023 Gusu District, Jiangsu, China

Yanming Biology

Biotechnology
Pharmaceutical
Therapeutics
$108M10 Jul 2023 Changping, Beijing, China

VDJ

Biotechnology
Medical
Pharmaceutical
06 Jun 2023 Haidian District, Beijing, China

Sijian Bio

Biotechnology
Health Care
Pharmaceutical
$15M31 May 2023 Pudong, Shandong, China

Hongyun Biotech

Biotechnology
Therapeutics
$15M15 May 2023 Nanjing, Jiangsu, China

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
20 Mar 2023 Changping District, Beijing, China

Care

Hardware
Health Diagnostics
Medical
Software
27 Feb 2023 Beijing, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: